Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation

被引:49
作者
Nakaseko, Chiaki [1 ]
Ozawa, Shinichi [1 ]
Sakaida, Emiko [1 ]
Sakai, Miwa [2 ]
Kanda, Yoshinobu [3 ]
Oshima, Kumi [3 ]
Kurokawa, Mineo
Takahashi, Satoshi [4 ]
Ooi, Jun [4 ]
Shimizu, Takayuki [5 ]
Yokota, Akira [7 ]
Yoshiba, Fumiaki [6 ,8 ]
Fujimaki, Katsumichi [9 ]
Kanamori, Heiwa [10 ]
Sakai, Rika [10 ,11 ]
Saitoh, Takayuki [12 ]
Sakura, Tohru [13 ]
Maruta, Atsuo [10 ]
Sakamaki, Hisashi [2 ]
Okamoto, Shinichiro [5 ]
机构
[1] Chiba Univ, Dept Hematol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[2] Tokyo Metropolitan Komagome Hosp, Dept Hematol, Tokyo, Japan
[3] Jichi Med Univ, Div Hematol, Saitama Med Ctr, Saitama, Japan
[4] Univ Tokyo, Dept Hematol & Oncol, Inst Med Sci, Tokyo, Japan
[5] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan
[6] Tokai Univ, Sch Med, Dept Med, Div Hematol & Oncol, Isehara, Kanagawa 25911, Japan
[7] Chiba Aoba Municipal Hosp, Dept Internal Med, Chiba, Japan
[8] Tokai Univ, Sch Med, Div Hematol & Oncol, Dept Med, Isehara, Kanagawa 25911, Japan
[9] Yokohama City Univ, Dept Internal Med & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan
[10] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan
[11] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa 232, Japan
[12] Gunma Univ, Dept Med & Clin Sci, Grad Sch Med, Maebashi, Gunma 371, Japan
[13] Saiseikai Maebashi Hosp, Div Hematol, Maebashi, Gunma, Japan
关键词
Bronchiolitis obliterans; Chronic GVHD; Late onset non-infectious pulmonary complications; PBSC; NONINFECTIOUS PULMONARY COMPLICATIONS; VERSUS-HOST-DISEASE; OBSTRUCTIVE LUNG-DISEASE; AIR-FLOW OBSTRUCTION; CHRONIC GRAFT; MARROW TRANSPLANTATION; DIAGNOSIS;
D O I
10.1007/s12185-011-0809-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bronchiolitis obliterans (BO) after allogeneic stem cell transplantation (allo-SCT) is a late-onset, life-threatening respiratory complication that significantly reduces a patient's quality of life. We retrospectively analysed the incidence of and risk factors for BO in allo-SCT recipients. In 2087 patients who underwent allo-SCT between January 1994 and June 2005 and survived > 90 days after transplantation, 57 patients developed BO with a 5-year cumulative incidence of 2.8%. The median time interval from transplantation to BO diagnosis was 335 days (range 83-907 days). The 5-year cumulative incidence of BO was 1.62% in bone marrow transplantation (BMT) from related donors, 3.83% in peripheral blood stem cell transplantation (PBSCT) from related donors (R-PBSCT), 2.91% in BMT from unrelated donors and 2.65% in unrelated cord blood transplantation. The incidence of BO after R-PBSCT was significantly higher than that after any other type of allo-SCT (p = 0.02). R-PBSCT (p = 0.019) and preceding chronic graft-versus-host disease (GVHD) (p < 0.001) were BO-associated risk factors. Overall 5-year survival of patients with BO from the time of diagnosis was 45.4%, significantly less than those without (77.5% from day 335, p < 0.001). R-PBSCT recipients with existent chronic GVHD have a high risk of developing BO, and need extensive care and repeated pulmonary function tests.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 22 条
[1]   Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation [J].
Afessa, B ;
Litzow, MR ;
Tefferi, A .
BONE MARROW TRANSPLANTATION, 2001, 28 (05) :425-434
[2]   Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation [J].
Bashoura, L. ;
Gupta, S. ;
Jain, A. ;
Couriel, D. R. ;
Komanduri, K. V. ;
Eapen, G. A. ;
Safdar, A. ;
Broglio, K. R. ;
Adachi, R. ;
Dickey, B. F. .
BONE MARROW TRANSPLANTATION, 2008, 41 (01) :63-67
[3]   Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation [J].
Chien, JW ;
Martin, PJ ;
Gooley, TA ;
Flowers, ME ;
Heckbert, SR ;
Nichols, WG ;
Clark, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) :208-214
[4]   OBSTRUCTIVE LUNG-DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION - CLINICAL PRESENTATION AND COURSE [J].
CLARK, JG ;
CRAWFORD, SW ;
MADTES, DK ;
SULLIVAN, KM .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (05) :368-376
[5]   RISK-FACTORS FOR AIR-FLOW OBSTRUCTION IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J].
CLARK, JG ;
SCHWARTZ, DA ;
FLOURNOY, N ;
SULLIVAN, KM ;
CRAWFORD, SW ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :648-656
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes [J].
Dudek, AZ ;
Mahaseth, H ;
DeFor, TE ;
Weisdorf, DJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (10) :657-666
[8]   National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report [J].
Filipovich, AH ;
Weisdorf, D ;
Pavletic, S ;
Socie, G ;
Wingard, JR ;
Lee, SJ ;
Martin, P ;
Chien, J ;
Przepiorka, D ;
Couriel, D ;
Cowen, EW ;
Dinndorf, P ;
Farrell, A ;
Hartzman, R ;
Henslee-Downey, J ;
Jacobsohn, D ;
McDonald, G ;
Mittleman, B ;
Rizzo, JD ;
Robinson, M ;
Schubert, M ;
Schultz, K ;
Shulman, H ;
Turner, M ;
Vogelsang, G ;
Flowers, MED .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) :945-956
[9]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481